ProKidney Corp. (PROK)

ProKidney Statistics

Total Valuation

ProKidney has a market cap or net worth of $234.57 million. The enterprise value is -$90.94 million.

Market Cap	234.57M
Enterprise Value	-90.94M

Important Dates

The last earnings date was Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ProKidney has 292.70 million shares outstanding. The number of shares has increased by 86.66% in one year.

Current Share Class	129.54M
Shares Outstanding	292.70M
Shares Change (YoY)	+86.66%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	21.85%
Owned by Institutions (%)	31.86%
Float	78.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	765.33
Forward PS	n/a
PB Ratio	0.63
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.96, with a Debt / Equity ratio of 0.01.

Current Ratio	10.96
Quick Ratio	10.07
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-25,666.29

Financial Efficiency

Return on equity (ROE) is -45.28% and return on invested capital (ROIC) is -30.25%.

Return on Equity (ROE)	-45.28%
Return on Assets (ROA)	-28.29%
Return on Invested Capital (ROIC)	-30.25%
Return on Capital Employed (ROCE)	-48.13%
Revenue Per Employee	$1,500
Profits Per Employee	-$335,431
Employee Count	204
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-105,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -79.56% in the last 52 weeks. The beta is 1.58, so ProKidney's price volatility has been higher than the market average.

Beta (5Y)	1.58
52-Week Price Change	-79.56%
50-Day Moving Average	0.84
200-Day Moving Average	1.60
Relative Strength Index (RSI)	48.87
Average Volume (20 Days)	802,565

Short Selling Information

The latest short interest is 15.64 million, so 5.34% of the outstanding shares have been sold short.

Short Interest	15.64M
Short Previous Month	13.28M
Short % of Shares Out	5.34%
Short % of Float	20.01%
Short Ratio (days to cover)	11.84

Income Statement

In the last 12 months, ProKidney had revenue of $306,000 and -$68.43 million in losses. Loss per share was -$0.60.

Revenue	306,000
Gross Profit	306,000
Operating Income	-179.66M
Pretax Income	-34.94M
Net Income	-68.43M
EBITDA	-173.73M
EBIT	-179.66M
Loss Per Share	-$0.60

Balance Sheet

The company has $328.50 million in cash and $3.37 million in debt, giving a net cash position of $325.13 million or $1.11 per share.

Cash & Cash Equivalents	328.50M
Total Debt	3.37M
Net Cash	325.13M
Net Cash Per Share	$1.11
Equity (Book Value)	369.98M
Book Value Per Share	-7.71
Working Capital	326.85M

Cash Flow

In the last 12 months, operating cash flow was -$121.30 million and capital expenditures -$29.68 million, giving a free cash flow of -$150.98 million.

Operating Cash Flow	-121.30M
Capital Expenditures	-29.68M
Free Cash Flow	-150.98M
FCF Per Share	-$0.52

Margins

Gross Margin	100.00%
Operating Margin	-58,713.73%
Pretax Margin	-54,267.65%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ProKidney does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-86.66%
Shareholder Yield	-86.66%
Earnings Yield	-29.22%
FCF Yield	-64.47%

Analyst Forecast

The average price target for ProKidney is $5.00, which is 523.91% higher than the current price. The consensus rating is "Buy".

Price Target	$5.00
Price Target Difference	523.91%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	276.60%
EPS Growth Forecast (5Y)	-20.88%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ProKidney has an Altman Z-Score of -1.01. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.01
Piotroski F-Score	n/a